Defence And Security Tenders

District Road Nes 28 Expansion of the Fladenen Town Thoroughfare

Aok - Priomed Secondary Prevention According to § 140A Sgb V

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Fulvestrant (Atc Code According to Who: L02ba03)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Certolizumab Pegol (Atc Code According to Who: L04ab05)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Infliximab (Atc Code According to Who: L04ab02)

Building Cleaning - Maintenance and Basic Cleaning

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Iron (Ii) Sulfate (B03aa07) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Eptinezumab (N02cd05) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Pimecrolimus (D11ah02) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Tolvaptan (G04bx21) as Part of a So-Called Open House Model.